Baidu
map

指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

2021 CSBrS实践指南：超声引导下真空辅助乳腺活检（英文版）

中国乳腺外科学会(CSBrS,Chinese Society of Breast Surgery)

超声引导下真空辅助乳腺活检手术乳腺活检影像学指导下乳腺活检

2021年6月，中国乳腺外科学会(CSBrS)发布了超声引导下真空辅助乳腺活检指南，主要目的是规范我国超声引导下真空辅助乳腺活检技术。

中文标题：

2021 CSBrS实践指南：超声引导下真空辅助乳腺活检（英文版）

英文标题：

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

发布机构：

发布日期：

简要介绍：

2021年6月，中国乳腺外科学会(CSBrS)发布了超声引导下真空辅助乳腺活检指南，主要目的是规范我国超声引导下真空辅助乳腺活检技术。

相关资料下载：
[AttachmentFileName(sort=1, fileName=Clinical_practice_guideline_for_breast.2.pdf)] GetToolGuiderByIdResponse(projectId=1, id=289271c002112010, title=2021 CSBrS实践指南：超声引导下真空辅助乳腺活检（英文版）, enTitle=Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021, guiderFrom=中国乳腺外科学会(CSBrS,Chinese Society of Breast Surgery), authorId=0, author=, summary=2021年6月，中国乳腺外科学会(CSBrS)发布了超声引导下真空辅助乳腺活检指南，主要目的是规范我国超声引导下真空辅助乳腺活检技术。, cover=https://img.medsci.cn/202167/1623035689080_5433779.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=null, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年6月，中国乳腺外科学会(CSBrS)发布了超声引导下真空辅助乳腺活检指南，主要目的是规范我国超声引导下真空辅助乳腺活检技术。</span></p>, tagList=[TagDto(tagId=65521, tagName=超声引导下真空辅助乳腺活检手术), TagDto(tagId=65522, tagName=乳腺活检), TagDto(tagId=99873, tagName=影像学指导下乳腺活检)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=65521, articleKeyword=超声引导下真空辅助乳腺活检手术, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2597, appHits=294, showAppHits=0, pcHits=861, showPcHits=2303, likes=6, shares=90, comments=33, approvalStatus=1, publishedTime=Mon Jun 07 11:15:44 CST 2021, publishedTimeString=null, pcVisible=1, appVisible=1, editorId=5433779, editor=Oranhyg是正经人, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=Oranhyg是正经人, createdTime=Mon Jun 07 11:15:38 CST 2021, updatedBy=5433779, updatedName=Oranhyg是正经人, updatedTime=Sat Jan 06 01:33:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Clinical_practice_guideline_for_breast.2.pdf)])
Clinical_practice_guideline_for_breast.2.pdf
下载请点击：
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193861, encodeId=d6961193861c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f60f5568994, createdName=ms4000001148740079, createdTime=Wed Feb 16 07:34:20 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065651, encodeId=27021065651e0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f65637290, createdName=ms4000000969798249, createdTime=Sun Oct 31 23:43:58 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004331, encodeId=2f12100433130, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51a25233326, createdName=147a5a6dm85暂无昵称, createdTime=Sun Aug 01 07:28:45 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978047, encodeId=00359e80471c, content=bucuo, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67205497763, createdName=国仁堂医药, createdTime=Tue Jun 29 23:14:38 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974851, encodeId=3fc39e48511b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Sat Jun 19 12:10:49 CST 2021, time=2021-06-19, status=1, ipAttribution=)]
    2022-02-16 ms4000001148740079

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193861, encodeId=d6961193861c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f60f5568994, createdName=ms4000001148740079, createdTime=Wed Feb 16 07:34:20 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065651, encodeId=27021065651e0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f65637290, createdName=ms4000000969798249, createdTime=Sun Oct 31 23:43:58 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004331, encodeId=2f12100433130, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51a25233326, createdName=147a5a6dm85暂无昵称, createdTime=Sun Aug 01 07:28:45 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978047, encodeId=00359e80471c, content=bucuo, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67205497763, createdName=国仁堂医药, createdTime=Tue Jun 29 23:14:38 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974851, encodeId=3fc39e48511b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Sat Jun 19 12:10:49 CST 2021, time=2021-06-19, status=1, ipAttribution=)]
    2021-10-31 ms4000000969798249

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193861, encodeId=d6961193861c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f60f5568994, createdName=ms4000001148740079, createdTime=Wed Feb 16 07:34:20 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065651, encodeId=27021065651e0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f65637290, createdName=ms4000000969798249, createdTime=Sun Oct 31 23:43:58 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004331, encodeId=2f12100433130, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51a25233326, createdName=147a5a6dm85暂无昵称, createdTime=Sun Aug 01 07:28:45 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978047, encodeId=00359e80471c, content=bucuo, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67205497763, createdName=国仁堂医药, createdTime=Tue Jun 29 23:14:38 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974851, encodeId=3fc39e48511b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Sat Jun 19 12:10:49 CST 2021, time=2021-06-19, status=1, ipAttribution=)]
    2021-08-01 147a5a6dm85暂无昵称

    好用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193861, encodeId=d6961193861c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f60f5568994, createdName=ms4000001148740079, createdTime=Wed Feb 16 07:34:20 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065651, encodeId=27021065651e0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f65637290, createdName=ms4000000969798249, createdTime=Sun Oct 31 23:43:58 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004331, encodeId=2f12100433130, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51a25233326, createdName=147a5a6dm85暂无昵称, createdTime=Sun Aug 01 07:28:45 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978047, encodeId=00359e80471c, content=bucuo, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67205497763, createdName=国仁堂医药, createdTime=Tue Jun 29 23:14:38 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974851, encodeId=3fc39e48511b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Sat Jun 19 12:10:49 CST 2021, time=2021-06-19, status=1, ipAttribution=)]
    2021-06-29 国仁堂医药

    bucuo

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193861, encodeId=d6961193861c2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f60f5568994, createdName=ms4000001148740079, createdTime=Wed Feb 16 07:34:20 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065651, encodeId=27021065651e0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f65637290, createdName=ms4000000969798249, createdTime=Sun Oct 31 23:43:58 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004331, encodeId=2f12100433130, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51a25233326, createdName=147a5a6dm85暂无昵称, createdTime=Sun Aug 01 07:28:45 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978047, encodeId=00359e80471c, content=bucuo, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67205497763, createdName=国仁堂医药, createdTime=Tue Jun 29 23:14:38 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974851, encodeId=3fc39e48511b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Sat Jun 19 12:10:49 CST 2021, time=2021-06-19, status=1, ipAttribution=)]
    2021-06-19 麻无赦

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

超声引导下真空辅助乳腺活检手术专家共识及操作指南（2017版）

中华医学会外科学分会 乳腺外科学组 · 2017-12-10

拓展阅读

2021 CSBrS实践指南：超声引导下真空辅助乳腺活检

乳房纤维腺瘤是妇女最常见的良性肿瘤，可发生在所有年龄段，常见于15-35岁的女性。

超声引导下真空辅助乳腺活检手术专家共识及操作指南（2017版）

中华医学会外科学分会乳腺外科学组组织国内部分专家在多次讨论的基础上，特制定本共识和手术操作指南。 本共识主要针对超声引导下VABB 对乳腺可疑病灶活检及良性病灶切除手术。不包括X 线摄影和MRI 引导下VABB 乳腺病灶手术。

Baidu
map
Baidu
map
Baidu
map